One Year Treatment with Omalizumab Is Effective and Well Tolerated in Japanese Patients with Moderate-to-Severe Persistent Asthma
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-06-01
著者
-
Miyamoto Terumasa
Japan Allergy Clinical Research Institute
-
OHTA Ken
Division of Respiratory Medicine, Department of Medicine, Teikyo University School of Medicine
-
YAMAMOTO Manabu
Clinical Development, Novartis Pharma K.K.
-
SATO Norio
Clinical Development, Novartis Pharma K.K.
-
IKEDA Kimitoshi
Clinical Development, Novartis Pharma K.K.
-
Ikeda Kimitoshi
Clinical Development Novartis Pharma K.k.
-
Yamamoto Manabu
Clinical Development Novartis Pharma K.k.
-
Ohta Ken
Division Of Respiratory Medicine Department Of Medicine Teikyo University School Of Medicine
-
Sato Norio
Clinical Development Novartis Pharma K.k.
-
OHTA Ken
Division of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine
関連論文
- Peak expiratory flow in normal healthy Japanese adults : Comparisons with values reported in other races
- Identifying Predictors of Response to Suplatast Tosilate among Patients with Moderate to Severe Bronchial Asthma Receiving Inhaled Steroid Therapy
- A basic policy for allergen standerdization in our country and standardization of Japanese cedar (Cryptomeria japonica) pollen extracts
- Effect of Transdermal Tulobuterol Added to Inhaled Corticosteroids in Asthma Patients
- Cost-effectiveness of budesonide Turbuhaler in the treatment of mild-to-moderate asthma in Japan
- One Year Treatment with Omalizumab Is Effective and Well Tolerated in Japanese Patients with Moderate-to-Severe Persistent Asthma
- A Case of Anaphylactic Reaction Following Matsutake Mushroom Ingestion : Demonstration of Histamine Release Reaction of Basophils
- Japanese Guideline for Adult Asthma